XML 36 R21.htm IDEA: XBRL DOCUMENT
v3.21.2

Impairment, Restructuring and COVID-19 Related Charges | 9 Months Ended
--- | ---
Oct. 30, 2021
Restructuring And Related Activities [Abstract] |
Impairment, Restructuring and COVID-19 Related Charges | 13. Impairment, Restructuring and COVID-19 Related Charges The following table represents impairment, restructuring and COVID-19 related charges for the 13 and 39 weeks ended October 31, 2020. There were no impairment, restructuring and COVID-19 related charges for the 13 and 39 weeks ended October 30, 2021. All amounts were recorded within impairment, restructuring and COVID-19 related charges on the Consolidated Statements of Operations.
|  | 13 Weeks Ended |  |  | 39 Weeks Ended |
|  | October 31, |  |  | October 31, |
(In thousands) |  | 2020 |  |  | 2020 |
Impairment charges (1) |  | $ | — |  |  | $ | 153,617 |
Incremental COVID-19 related expenses (2) |  |  | 5,951 |  |  |  | 19,836 |
Severance and related employee costs |  |  | 1,004 |  |  |  | 3,733 |
Total impairment, restructuring and COVID-19 related charges |  | $ | 6,955 |  |  | $ | 177,186 |
(1) During the 39 weeks ended October 31, 2020, the Company recorded asset impairment charges of $153.6 million. Included in this amount are retail store impairment charges of $109.6 million, of which $84.1 million relates to operating lease ROU assets and $25.5 million relates to store property and equipment (fixtures and equipment and leasehold improvements). We also recorded $26.0 million of impairment related charges to certain corporate property and equipment, as well as $18.0 million of impairment charges related to certain cost and equity method investments. (2) Incremental COVID-19 related expenses consist of personal protective equipment and supplies for our associates and customers. A roll-forward of restructuring liabilities recognized in accrued compensation and payroll taxes and other current liabilities and accrued expenses in the Consolidated Balance Sheet is as follows:
|  | 39 Weeks Ended |
|  | October 30, |
(In thousands) |  | 2021 |
Restructuring liability as of January 30, 2021 |  | $ | 2,812 |
Add: Costs incurred, excluding non-cash charges |  |  | — |
Less: Cash payments and adjustments |  |  | (2,421 | )
Restructuring liability as of October 30, 2021 |  | $ | 391 |

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration